By deciphering RNA, we're opening the door to a new era of patient treatment.
Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today don’t respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.
Total Funding: $35M
Funding Stage: Series B
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 26 to 50
Founded: 2014
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at Scipher Medicine
Senior Data Scientist-Network Medicine
Waltham, Massachusetts
Provider Relations Representative
Waltham, Massachusetts
Product Marketing Manager
Waltham, Massachusetts
Director, Drug Discovery
Waltham, Massachusetts
Clinical Research Associate
Waltham, Massachusetts
Scipher Medicine - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups Scipher Medicine - Manage Profile